<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">RIFAXIMIN</span><br/>(ri-fax'i-min)<br/><span class="topboxtradename">Xifaxan<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">rifamycin antibiotic</span><br/><b>Prototype: </b>Rifampin <br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>200 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>A rifamycin antibiotic structurally related to rifampin. Its spectrum of activity includes gram-positive and gram-negative
         aerobes and anaerobes. 
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Coverage against gram-positive cocci is better than its coverage against <i>Enterobacteriaceae</i>. Inhibits <i>E. coli</i> RNA synthesis. Unlike other rifamycin antibiotics, rifaximin is largely unabsorbed by the GI tract in subjects with intact
         and damaged intestinal mucosa.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of traveler's diarrhea cause by noninvasive strains of <i>E. coli</i>.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to rifaximin, other rifamycin antimicrobial agents or to any of its components; ulcerative intestinal disease;
         dysentery; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Diarrhea with fever and/or blood in the stool, or diarrhea due to organisms other than <i>E. coli;</i> worsening diarrhea or diarrhea persisting for &gt;2448 h.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Traveler's Diarrhea</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 200 mg t.i.d. for 3 d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>May be given without regard to food.</li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Fever. <span class="typehead">CNS:</span> Headache. <span class="typehead">GI:</span> <span class="speceff-common">Flatulence,</span> abdominal pain, rectal tenesmus, defecation urgency, nausea, constipation, vomiting. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Peak: 1.21 h. <span class="typehead">Elimination:</span> Eliminated in feces. <span class="typehead">Half-Life:</span> 5.85 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Withhold drug and notify physician if symptoms worsen or last &gt;48 h after starting drug; an alternative treatment should be
            considered.
         </li>
<li>Report promptly the appearance of blood in the stool.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report promptly any of the following: fever; difficulty breathing; skin rash, itching, or hives; worsening diarrhea during
            or after treatment or blood in the stool.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>